MUCOCUTANEOUS ADVERSE EFFECTS IN PATIENTS UNDERGOING CANCER CHEMOTHERAPY

Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 42

Abstract

BACKGROUND New chemotherapeutic agents and new protocols in oncology have led to an increasing survival rate in patients affected by tumours. Traditional chemotherapy drugs as well as the newer targeted agents are associated with a wide array of cutaneous toxicities.[1] Toxic effects on skin, hair and nails can negatively affect the quality of life and also lead to interruption or discontinuation of these drugs.[2] Aim- To study the various mucocutaneous adverse effects associated with cancer chemotherapy. MATERIALS AND METHODS A total of 200 patients with malignancies undergoing chemotherapy in the oncology ward and outpatient department were screened in this observational study. We have clinically examined 200 patients affected by cancer determining type, treatment and evolution of cutaneous side effects related to chemotherapy. It is a hospital-based observational study. All patients were counselled about the study and informed written consent was obtained. Patients were examined before start of chemotherapy treatment and after every cycle of chemotherapy. Data collected was analysed using SPSS version 16.0. RESULTS In this study, 200 patients including 118 females and 82 males were studied. Majority (56%) of the patients belonged to the age group of 41 - 60 years. The common indications for chemotherapy were carcinoma breast (29%), tongue (11%), buccal mucosa (10%), ovary (8%) and stomach (6%). Among the cutaneous adverse events noted, hair changes were the most common presentation and were reported in 156 (78%) patients. Skin changes were seen in 130 (65%) cases, nail changes in 102 (51%) cases and mucosal changes in 46 (23%) patients. Cisplatin, cyclophosphamide, 5-fluorouracil, carboplatin, paclitaxel and doxorubicin were the most frequently prescribed chemotherapeutic drugs. CONCLUSION Oncological therapies have become more selective and have low systemic toxicity because of their high specificity, but cutaneous side effects are common and may worsen the quality of life of these patients. Our observations necessitate a joint effort between dermatology and oncology for the early recognition and adequate treatment of the cutaneous adverse effects associated with cancer chemotherapy, which may help in reducing morbidity and improving compliance.

Authors and Affiliations

Garima Sharma, P. K. Nigam

Keywords

Related Articles

DETERMINATION OF LEVELS OF SERUM ALBUMIN AND ABSOLUTE CD4+ CELL COUNTS IN HIV INFECTED INDIVIDUALS

BACKGROUND CD4+ cell counts and HIV RNA levels have been widely accepted as the most powerful prognostic indicators of HIV disease progression. Recent studies have suggested that low levels of serum albumin are associate...

CASE SERIES OF FEMORAL SHAFT FRACTURES INNOVATIVELY MANAGED BY USING REAMED MATERIAL AS INTERNAL BONE GRAFT FOR EARLY FRACTURE UNION

BACKGROUND Femur fracture treatment has constantly evolved over time from various conservative methods to various newer modalities of fixation. Since the incidence of malunion and non-union in conservative methods was mo...

 A COMPARATIVE STUDY OF FINE NEEDLE ASPIRATION CYTOLOGY, ULTRASONOGRAPHY AND RADIONUCLIDE SCAN IN MANAGEMENT OF SOLITARY THYROID NODULE: A PROSPECTIVE ANALYSIS OF FIFTY CASES

 Solitary thyroid nodule is a common clinical entity encountered by the otorhinolaryngologist and physicians. The optimum diagnostic strategy for euthyroid patient with a solitary nodule thyroid is still a matte...

STANDARDISATION AND COMPARISON OF DIFFERENT METHODS FOR PREPARING PLATELET RICH PLASMA

BACKGROUND Platelet rich plasma (PRP) is defined as a volume of the plasma fraction of autologous blood with an above baseline platelet concentration. Platelet releases the growth factors from their granules that are ben...

COMPARISON OF INTRAVENOUS PARACETAMOL AND TRAMADOL AS PRE-EMPTIVE ANALGESIC FOR LOWER ABDOMINAL SURGERIES IN CHILDREN- A PROSPECTIVE RANDOMISED DOUBLE-BLIND STUDY

BACKGROUND Pre-emptive analgesia is administration of an analgesic before a painful stimulus, so as to prevent central sensitisation. Intravenous (IV) formulation of paracetamol has been introduced and its safety and pha...

Download PDF file
  • EP ID EP548518
  • DOI 10.14260/jemds/2018/1012
  • Views 55
  • Downloads 0

How To Cite

Garima Sharma, P. K. Nigam (2018). MUCOCUTANEOUS ADVERSE EFFECTS IN PATIENTS UNDERGOING CANCER CHEMOTHERAPY. Journal of Evolution of Medical and Dental Sciences, 7(42), 4535-4538. https://europub.co.uk/articles/-A-548518